News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Netflix shares are down over 50% from highs, trading near $63 with mid‑teens P/E and producing free cash flow.
  • Some investors recommend buying Netflix's pullback with defined stops and a multi‑month horizon.
  • Bitcoin traded above $76,000 as cryptocurrency prices showed tentative stabilization.
  • Large net redemptions from U.S. spot Bitcoin ETFs underscore that institutional demand remains fragile.
  • Broader crypto markets were mixed, with Ether and several altcoins up while XRP lagged.

Latest Articles

Rubico Announces Record Date of Monday, September 28 and Ex-Dividend Date of Tuesday, October 6 for Previously-Announced 0.50 Common Shares Per Common Share Stock Dividend

Rubico Announces Record Date of Monday, September 28 and Ex-Dividend Date of Tuesday, October 6 for Previously-Announced 0.50 Common Shares Per Common Share Stock Dividend

Rubico Inc., a Nasdaq-listed global shipping service provider, announces the record date of September 28, 2026, and an ex-dividend date of October 6, 2026 for its previously declared 0.50 common shares stock dividend. The company outlines due bill trading procedures and confirms the distribution will be on or about October 5, 2026. Rubico also upda…

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

SELLAS Life Sciences announced preclinical results revealing that SLS009, their selective CDK9 inhibitor, significantly increased apoptosis and necrosis in MYC-amplified, daraxonrasib-resistant pancreatic cancer models. The combination of SLS009 with daraxonrasib or BET inhibitor ZEN3694 demonstrated synergistic effects, supporting the potential of…

Home Depot at a Discount: 3.2% Yield and an Oversold Setup Worth a Trade

Home Depot at a Discount: 3.2% Yield and an Oversold Setup Worth a Trade

Home Depot (HD) has pulled back to the low $290s after a weak housing backdrop and macro volatility. At a ~$294B market cap, a 3.2% yield, and strong free cash flow, HD looks like an attractive tactical long for investors willing to accept near-term housing risk. This trade lays out entry at $295.03, a $280 stop and a $360 target over a 180-trading…

Buy the Pullback in Syndax Ahead of Q4 Clinical Readouts

Buy the Pullback in Syndax Ahead of Q4 Clinical Readouts

Syndax (SNDX) has converted clinical success into commercial traction: two approved therapies and $172.4M in annual revenue. The stock has pulled back into technical support with RSI ~43 and price near the 10-day SMA. We view a measured long on weakness as an attractive trade ahead of expected Q4 readouts and ongoing commercialization catalysts. En…

TSMC: The Foundry Bet on AI — A Long-Term Trade with Defined Risk

TSMC: The Foundry Bet on AI — A Long-Term Trade with Defined Risk

Taiwan Semiconductor Manufacturing Co. (TSM) sits at the heart of the AI hardware supply chain. With dominant fabrication share, large-scale capital commitments, and favorable technical momentum, TSM is a pragmatic way to play secular AI demand. This trade plan defines an actionable long position with a clear entry at $453.38, a stop at $420.00 and…

SS&C's Acquisition Flywheel: Buying the Cash-Generating Engine

SS&C's Acquisition Flywheel: Buying the Cash-Generating Engine

SS&C Technologies is turning steady recurring software revenue and sizable free cash flow into a compounding acquisition engine. At roughly $18.5B market cap and $1.75B in free cash flow, management can both pay down debt and bolt on software franchises that expand margins and sticky revenue. This trade targets a re-rating toward a mid-20s P/E over…

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

OneMedNet Corporation will execute a 1-for-10 reverse stock split effective September 29, 2026, approved by shareholders to comply with Nasdaq Capital Market's minimum bid price rules and to potentially broaden investor interest. The reverse split reduces outstanding shares from approximately 59.3 million to about 5.9 million, with proportional adj…

Backing Domino's Pizza Group: A U.K.-Focused Trade Over the U.S. Parent

Backing Domino's Pizza Group: A U.K.-Focused Trade Over the U.S. Parent

Domino's Pizza Group (DOM) is my preferred way to play the global Domino's brand over the larger U.S. parent. The U.K. business combines a lightweight capital model, steady unit economics, and clearer near-term catalysts — making it a pragmatic mid-term trade. I lay out an entry, stop and target with a 45 trading day horizon and a balanced risk fra…

Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026

Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026

Pinnacle Acquisition Corporation announced that starting September 25, 2026, investors will be able to trade the company's Class A ordinary shares and rights separately, following their initial trading as units in the IPO. The shares and rights will trade under the symbols 'PNAQ' and 'PNAQ.RT' respectively on the New York Stock Exchange. Pinnacle A…

Oracle: Buy the Dip — Position for an OCI-Driven Re-rate

Oracle: Buy the Dip — Position for an OCI-Driven Re-rate

Oracle has been accused of being slow to the cloud and AI party, but its underlying cash generation, sticky enterprise contracts, accelerating OCI traction, and aggressive capital return make short-term execution noise a buying opportunity. This trade idea lays out a clear entry, stop, and target for a 180-trading-day campaign to capture a valuatio…

ChangeNOW Maps Out TOKEN2049 Singapore Agenda: Booth Experience, Bit Digital Keynote, and Fast Track Wallet Program

ChangeNOW Maps Out TOKEN2049 Singapore Agenda: Booth Experience, Bit Digital Keynote, and Fast Track Wallet Program

ChangeNOW has published its TOKEN2049 Singapore schedule, centering on a booth that blends retrofuturism and Japanese Metabolism, a Fast Track Program to onboard early-stage wallets, a limited CoolWallet co-branded hardware run, and a series of talks and partner events on October 6-8. The company will host a central podcast studio, PR and partner s…

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Pharming Group announced that the U.S. FDA has accepted for Priority Review its supplemental New Drug Application seeking approval for lower doses of Joenja® (leniolisib) to treat children aged 4 years and older weighing between 13 kg and 27 kg with activated phosphoinositide 3-kinase delta syndrome (APDS). The FDA's target action date is January 3…

Starbucks: Operational Fixes Complete — Time to Own the Rebound

Starbucks: Operational Fixes Complete — Time to Own the Rebound

Starbucks has checked the boxes on digital and daypart execution, posted consecutive comp growth, and sits on solid cash flows. Valuation is rich but technicals show oversold conditions and catalysts — from a near-complete digital menu rollout to upcoming results — make a mid-term long trade attractive. Upgrade to BUY for a mid-term (45 trading day…